{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cholesteatoma/management/suspected-cholesteatoma/","result":{"pageContext":{"chapter":{"id":"2a0a9f3d-521e-5fbc-86dc-bc1eb8313e42","slug":"suspected-cholesteatoma","fullItemName":"Scenario: Suspected cholesteatoma","depth":2,"htmlHeader":"<!-- begin field 0b5c1aa8-aed6-4e32-9d8b-fef54fd71740 --><h2>Scenario: Suspected cholesteatoma</h2><!-- end field 0b5c1aa8-aed6-4e32-9d8b-fef54fd71740 -->","summary":"Covers the management of suspected cholesteatoma in primary care and when to refer to secondary care.","htmlStringContent":"<!-- begin item 329d7f8f-74bc-4820-baaf-f54a655f39ca --><!-- begin field 97eeb165-eea2-4357-bb60-acbd008600b6 --><p>From birth onwards.</p><!-- end field 97eeb165-eea2-4357-bb60-acbd008600b6 --><!-- end item 329d7f8f-74bc-4820-baaf-f54a655f39ca -->","topic":{"id":"4aada4a1-a367-5618-bf4c-69f56c02369e","topicId":"ca3de7f0-81b2-498d-bfdf-5d2f1cb03753","topicName":"Cholesteatoma","slug":"cholesteatoma","lastRevised":"Last revised in July 2020","chapters":[{"id":"d42429ea-5002-5771-880d-4290978fcf9f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5316a5a7-bf50-542f-9aaf-c83efbea8228","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"21b30210-3d5c-55f1-be98-58f90cf96b8a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c58a93d1-7a8f-5e2a-a947-6f0608c604ae","slug":"changes","fullItemName":"Changes"},{"id":"5ea4eac3-9cdc-55fa-b682-a9ec0af2269d","slug":"update","fullItemName":"Update"}]},{"id":"7e4f1a56-3290-5055-973a-6b63c8017a6e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"acbd686d-62d4-59f7-919d-eac46eb3a523","slug":"goals","fullItemName":"Goals"},{"id":"b422727e-d031-54b7-b5da-ae88d8d34a98","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"45f2c172-64e7-521d-86d9-30d2e6c6fe42","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ca6b501d-5f48-5120-8174-bc1529ba7187","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b6c29a13-cd1d-5d17-b8af-822dcbac7a95","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e968efbe-fd7b-59e0-986d-f0ba231d08ca","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8c92d03c-0813-5611-96f2-ca98feb75297","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"94a4e9e8-0274-52e0-8ed3-97f857628e9e","slug":"definition","fullItemName":"Definition"},{"id":"067f91d0-28bb-560c-a431-6d8240f03fbf","slug":"prevalence","fullItemName":"Prevalence"},{"id":"eee089c5-e163-5989-9617-58f18afdfd14","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"386b6357-bbbf-5cd0-b597-d06b18555ca5","slug":"prognosis","fullItemName":"Prognosis"},{"id":"cefed4ca-14a8-5b24-8a70-2360696b5da9","slug":"complications","fullItemName":"Complications"}]},{"id":"0a843b90-e09f-58bb-a58e-f6899caf17b0","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"670c060b-185b-5cad-a581-cb75e3b68e8e","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"00b3e897-19a0-52da-9d4c-5feecd995f22","fullItemName":"Management","slug":"management","subChapters":[{"id":"2a0a9f3d-521e-5fbc-86dc-bc1eb8313e42","slug":"suspected-cholesteatoma","fullItemName":"Scenario: Suspected cholesteatoma"}]},{"id":"757fbe56-0d18-5e26-869c-4ed901c606c1","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7aa34852-de13-5651-8068-1af17c6752da","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3cd8bcf6-eb80-5737-93ef-a0e704dada7a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"28b150f0-bb01-516e-b486-13b2f5befe72","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0559f567-3b5b-55ca-a720-9939fe97680b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b5f4520-173f-5e27-86a2-5da01dd7d623","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f1c122c1-f371-53ad-9709-292997e07279","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4409b199-98e2-5928-856f-62ac86897872","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"00b3e897-19a0-52da-9d4c-5feecd995f22","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"bdbf353f-a28b-5794-90e5-2afb0cbc3258","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 4842dfd5-86f8-4689-a809-93781fc817fb --><h3>How do I manage someone with suspected cholesteatoma?</h3><!-- end field 4842dfd5-86f8-4689-a809-93781fc817fb -->","summary":null,"htmlStringContent":"<!-- begin item 0e0a0383-beb9-4be7-8c83-9fcac480d451 --><!-- begin field 3570fc8c-93c0-46c2-a59f-9ec49eaa520b --><ul><li><strong>For all people with suspected cholesteatoma, arrange semi-urgent referral to an ear, nose, and throat specialist.</strong><ul><li>Investigations carried out in secondary care will include an audiology assessment and a CT scan.</li><li>Prior to surgical treatment, aural discharge may be treated with topical antibiotics. </li><li>A commonly-employed surgical treatment for cholesteatoma is a canal wall up mastoidectomy, which allows removal of cholesteatoma but leaves the canal wall intact. This usually necessitates a second-look procedure after 9 to 12 months to examine for residual/recurrent disease.</li></ul></li><li><strong>Arrange emergency admission </strong><strong>for people who have:</strong><ul><li>A facial nerve palsy or vertigo.</li><li>Other neurological symptoms (including pain) or signs that could be associated with the development of an intracranial abscess or meningitis.</li></ul></li></ul><!-- end field 3570fc8c-93c0-46c2-a59f-9ec49eaa520b --><!-- end item 0e0a0383-beb9-4be7-8c83-9fcac480d451 -->","subChapters":[{"id":"3509e29e-655e-556b-8919-d698e683ea40","slug":"basis-for-recommendation-b3d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8ec821b4-905f-411e-b0c3-dd7e63db28bd --><h4>Basis for recommendation</h4><!-- end field 8ec821b4-905f-411e-b0c3-dd7e63db28bd -->","summary":null,"htmlStringContent":"<!-- begin item b3d2c100-4100-4c4f-a15d-f36724df14ca --><!-- begin field 1649455d-a53d-45ab-8a79-a028f38206c7 --><p>The information on management of cholesteatoma is largely based on expert opinion within the BMJ Best Practice guideline <em>Cholesteatoma</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholesteatoma/references/\">BMJ Best Practice, 2019</a>].</p><h5>Admission and referral</h5><ul><li>The recommendations on symptoms that should provoke emergency admission are also based on expert opinion within a BMJ review article <em>Easily missed? Cholesteatoma</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholesteatoma/references/\">Bhutta et al, 2011</a>] which states that:<ul><li>For people with a facial nerve palsy or vertigo, delayed treatment is associated with a worse prognosis.</li><li>Other neurological symptoms (including pain) may be an indication that the cholesteatoma is associated with the development of an intracranial abscess or meningitis.</li></ul></li><li>Experts recommend referral for all other people because surgical intervention is always required [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholesteatoma/references/\">Swan, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholesteatoma/references/\">Bhutta et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholesteatoma/references/\">BMJ Best Practice, 2019</a>]. </li></ul><!-- end field 1649455d-a53d-45ab-8a79-a028f38206c7 --><!-- end item b3d2c100-4100-4c4f-a15d-f36724df14ca -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}